Autolus Therapeutics plc (AUTL)
About Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $75.4M
- Net income
- -$287.5M
- Total assets
- $589.1M
- Market cap
- $385.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $385.9M
- Shares outstanding
- 250.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 22, 2018
Autolus Therapeutics plc (AUTL) Stock Price
- Reported a net loss of $287.5M in FY2025.
- Trading 39% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Autolus Therapeutics plc.
Write a review
News about Autolus Therapeutics plc
News & sentiment via Polygon.io
Autolus Therapeutics plc: frequently asked questions
Is Autolus Therapeutics plc an American company?
Autolus Therapeutics plc is a US-based company headquartered in London, X0, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Autolus Therapeutics plc headquartered?
Autolus Therapeutics plc is headquartered in London, X0, United States.
Is Autolus Therapeutics plc publicly traded?
Yes — Autolus Therapeutics plc is a publicly traded company. Its stock trades under the ticker symbol AUTL on the NASDAQ.
What does Autolus Therapeutics plc do?
Autolus Therapeutics plc is an American Pharmaceuticals company in the Health & Beauty sector.
When was Autolus Therapeutics plc founded?
Autolus Therapeutics plc was founded in 2014.
